Mucormycosis, a rare but deadly fungal infection, was an epidemic during the COVID-19
pandemic. The rise in cases (COVID-19-associated mucormycosis, CAM) is attributed to …

A fungal infection or mycosis is a disease that can affect humans in various ways. These
pathogens, being eukaryotic organisms, can invade their eukaryotic hosts, leading to …

BACKGROUND Mucormycosis is a rare, rapidly progressive and often fatal fungal infection.
The rarity of the condition lends itself to unfamiliarity, delayed treatment, and poor outcomes …

Background This study aimed to estimate the disease burden and describe the clinical
presentation, risk factors, and outcome of CAM in a single centre in Iran. Methods A case of …

Background Due to a delay in diagnosis by conventional techniques and high mortality, the
development of a standardised and rapid non‐culture‐based technique is an unmet need in …

During the COVID-19 pandemic, a significant increase in cases of mucormycosis was
observed in COVID-19 patients, especially in India, but not exclusively. The presented cases …

Aim: Currently, we have limited armamentarium of antifungal agents against Mucorales.
There is an urgent need to discover novel antifungal agents that are effective, safe and …

The emergence of COVID-19, caused by severe acute respiratory syndrome coronavirus-2
(SARS-CoV-2), triggered a global pandemic. Concurrently, reports of mucormycosis cases …

Abstract Purpose of Review The current review gives a proper understanding of the various
dynamics of COVID-associated mucormycosis (CAM). We provide insight into the agent and …

Mucormycosis was highly prevalent during the coronavirus disease 2019 pandemic,
particularly during the second wave, causing increased health risks to immunosuppressed …